Navigation Links
Expression Injectable by Enhancement Medical – Adverse Events: AttorneyOne Monitors and Keeps Consumers Informed
Date:8/8/2014

San Diego, CA (PRWEB) August 08, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Expression Injectable.

The FDA issued a safety communication on August 5, on adverse events associated with the unapproved use of the Expression product as a dermal filler. Expression is used as an intranasal splint, intended to minimize bleeding and swelling and to prevent adhesions between the septum and the nasal cavity.

FDA’s reason for the safety communication is that the Agency became aware of adverse events, related to unapproved use, that included itching, discoloration, redness, bruising, pain, bumps, lumps, firmness, tenderness, swelling, and the development of hard nodules.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds, “We are determined to keep an eye on FDA announcements concerning Expression Injectable and inform the public. For that reason," he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

The FDA recommends that “health care providers stop using Expression by Enhancement Medical LLC as a subcutaneously administered substance and instead use the list of FDA approved fillers.” And the Agency adds “patients who have received treatment with Expression as a dermal filler should be monitored for adverse events and referred for corrective treatment when appropriate.”

AttorneyOne.com has further information on Expression Injectable at the website including latest major drug, food, and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/08/prweb12077689.htm.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12081219.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Barriers to obtaining gene expression profiling test heightened perceived value
2. Overexpression of Notch1 in temporal lobe epilepsy
3. TAG-1 induces apoptosisrelated gene expression without triggering glioma apoptosis
4. Shuganjieyu capsule increases neurotrophic factor expression in a rat model of depression
5. Variable gene expression in zebrafish
6. Occludin and connexin 43 expression in the pathogenesis of traumatic brain edema
7. Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence
8. Researchers report a complete description of gene expression in the human retina
9. Advancement in Biologic Protein Expression Webinar Hosted by Selexis SA
10. Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence
11. McHugh Plastic Surgery & Secret Expressions Med Spa Offer Injection Day Specials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Clearwater, FL (PRWEB) , ... March 27, 2017 ... ... accepts new patients for clear braces. People who want straight teeth without the ... Invisalign® in Clearwater, FL, without acquiring a referral. A custom-designed series ...
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... 3.0 was transitioned to the OSEHRA popHealth Community in 2014. It ... Work Group and the Developer Open Source Project Group. OSEHRA Organizational Member Zato ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon ... industry standards and specifications such as ANSI, ISO and proven test methods used ...
(Date:3/27/2017)... ... 27, 2017 , ... Advantexe Learning Solutions , a ... a new research study, The Business Readiness Report. The report explores the correlation ... the actual success of achieving individual and company goals. , There are ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the ... including all stages, is more than 95%. Once the cancer spreads to other organs, ... 30%. To find out how to avoid this latter group, tune in to ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... , March 27, 2017 Invivotek, LLC, a ... in vivo pharmacology contract research organization (CRO), ... to its newly expanded preclinical research facility in ... provides a cleaner, renewable energy source to reduce costs ... Completion of the Genesis Solar Farm follows Invivotek,s recent ...
(Date:3/24/2017)... 24, 2017  Zymo Research Corp., also ... Robotics, Inc., who designs, manufactures and distributes ... that teams Zymo Research,s DNA methylation detection ... extraction products with Hamilton,s high-throughput automation platforms. ... for microbiomics and RNA isolation for use ...
Breaking Medicine Technology: